Close Menu

NEW YORK – Quidel announced preliminary second quarter results after the market closed Monday, saying that it expects to report a revenue increase in the range of 86 to 87 percent over the prior-year quarter. The firm attributed the increase to demand for its COVID-19-related diagnostic products.

Quidel said it expects revenues for Q2 2020 to be in the range of $201 million to $202 million. The firm's revenues for Q2 2019 were $108.3 million, as previously reported.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.